Quantum Biopharma (QNTM) Change in Account Payables (2019 - 2026)

Quantum Biopharma has reported Change in Account Payables for 8 years, with the latest figure at -$3.3 million in Q1 2026.

• Quarterly Change in Account Payables fell 1738.04% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 137.07% YoY) and the FY2025 annual result came in at $1.2 million, down 72.4% from the prior year.
• Change in Account Payables retreated to -$3.3 million in Q1 2026 per QNTM's latest filing, from -$214343.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $3.1 million in Q4 2024 and troughed at -$3.3 million in Q1 2026.
• A 5-year average of $208048.6 and a median of $438640.0 in 2022 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2024 and 2026: Change in Account Payables soared 443.46% in 2024, then sank 1738.04% in 2026.
• Over 5 years, Change in Account Payables stood at $723769.0 in 2022, then slipped by 20.54% to $575080.0 in 2023, then jumped by 443.46% to $3.1 million in 2024, then slumped by 106.86% to -$214343.0 in 2025, then sank by 1421.9% to -$3.3 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$3.3 million, -$214343.0, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.